Introduction: Asbestos is a global occupational health hazard, and exposure to it by inhalation predisposes to interstitial as well as malignant pulmonary morbidity. Over time, asbestos fibers embedded in lung tissue can become coated with iron-rich proteins and mucopolysaccharides, after which they are called asbestos bodies (ABs) and can be detected in light microscopy (LM). Bronchoalveolar lavage, a cytological sample from the lower airways, is one of the methods for diagnosing lung asbestosis and related morbidity. Search for ABs in these samples is generally laborious and time-consuming. We describe a novel diagnostic method, which implements deep learning neural network technology for the detection of ABs in bronchoalveolar lavage samples (BALs). Methods: BALs with suspicion of asbestos exposure were scanned as whole slide images (WSIs) and uploaded to a cloud-based virtual microscopy platform with a neural network training interface. The images were used for training and testing a neural network model capable of recognizing ABs. To prioritize the model’s sensitivity, we allowed it to also make false-positive suggestions. To test the model, we compared its performance to standard LM diagnostic data as well as the ground truth (GT) number of ABs, which we established by a thorough manual search of the WSIs. Results: We were able to reach overall sensitivity of 93.4% (95% CI: 90.3–95.7%) in the detection of ABs in comparison to their GT number. Compared to standard LM diagnostic data, our model showed equal to or higher sensitivity in most cases. Conclusion: Our results indicate that deep learning neural network technology offers promising diagnostic tools for routine assessment of BALs. However, at this stage, a human expert is required to confirm the findings.

Journal Section:
Techniques
Keywords:
Asbestos, Asbestos bodies, Bronchoalveolar lavage, Deep learning, Neural network, Virtual microscopy
1.
Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scand J Work Environ Health. 2015;41(1):5–15.
https://doi.org/10.5271/sjweh.3462
2.
Cullinan P, Muñoz X, Suojalehto H, Agius R, Jindal S, Sigsgaard T, et al. Occupational lung diseases: from old and novel exposures to effective preventive strategies. Lancet Respir Med. 2017;5(5):445–55.
https://doi.org/10.1016/S2213-2600(16)30424-6
3.
Pira E, Donato F, Maida L, Discalzi G. Exposure to asbestos: past, present and future. J Thorac Dis. 2018;10(Suppl 2):S237–45.
https://doi.org/10.21037/jtd.2017.10.126
4.
Sen D. Working with asbestos and the possible health risks. Occup Med. 2015;65(1):6–14.
https://doi.org/10.1093/occmed/kqu175
5.
Churg AM, Warnock ML. Asbestos and other ferruginous bodies. Their formation and clinical significance. Am J Pathol. 1981;102(3):447–56.
6.
Wheeler TM, Johnson EH, Coughlin D, Greenberg SD. The sensitivity of detection of asbestos bodies in sputa and bronchial washings. Acta Cytol. 1988;32(5):647–50.
7.
Oury TD, Sporn TA, Roggli VLPathology of asbestos-associated diseases. 3rd ed. Pathology of Asbestos-Associated Diseases; 2014. p. 1–357.
8.
Karjalainen A, Piipari R, Mäntylä T, Mönkkönen M, Nurminen M, Tukiainen P, et al. Asbestos bodies in bronchoalveolar lavage in relation to asbestos bodies and asbestos fibres in lung parenchyma. Eur Respir J. 1996;9(5):1000–5.
https://doi.org/10.1183/09031936.96.09051000
9.
Keskitalo E, Varis L, Bloigu R, Kaarteenaho R. Bronchoalveolar cell differential count and the number of asbestos bodies correlate with survival in patients with asbestosis. Occup Environ Med. 2019;76(10):765–71.
https://doi.org/10.1136/oemed-2018-105606
10.
Ferreira R, Moon B, Humphries J, Sussman A, Saltz J, Miller R, et al. The virtual microscope. Proc AMIA Annu Fall Symp. 1997;4(Suppl):449–53.
11.
Afework A, Beynon MD, Bustamante F, Cho S, Demarzo A, Ferreira R, et al. Digital dynamic telepathology: the virtual microscope. Proc AMIA Symp. 1998:912–6.
12.
Lundin M, Lundin J, Isola J. Virtual microscopy. J Clin Pathol. 2004;57(12):1250–1.
https://doi.org/10.1136/jcp.2004.019919
13.
Kumar N, Gupta R, Gupta S. Whole Slide Imaging (WSI) in pathology: current perspectives and future directions. J Digit Imaging. 2020;33(4):1034–40.
https://doi.org/10.1007/s10278-020-00351-z
14.
Hanna MG, Parwani A, Sirintrapun SJ. Whole slide imaging: technology and applications. Adv Anat Pathol. 2020;27(4):251–9.
https://doi.org/10.1097/PAP.0000000000000273
15.
Al-Janabi S, Huisman A, Van Diest PJ. Digital pathology: current status and future perspectives. Histopathology. 2012;61(1):1–9.
https://doi.org/10.1111/j.1365-2559.2011.03814.x
16.
Tolonen T, Näpänkangas J, Isola J. Clinical pathology on the verge of virtual microscopy | Kliininen patologia virtuaalimikroskopian kynnyksellä. Duodecim. 2015;131(21):1981–7.
17.
Sali R, Moradinasab N, Guleria S, Ehsan L, Fernandes P, Shah TU, et al. Deep learning for whole-slide tissue histopathology classification: a comparative study in the identification of dysplastic and non-dysplastic barrett’s esophagus. J Pers Med. 2020;10(4):141–16.
https://doi.org/10.3390/jpm10040141
18.
Fenstermaker M, Tomlins SA, Singh K, Wiens J, Morgan TM. Development and validation of a deep-learning model to assist with renal cell carcinoma histopathologic interpretation. Urology. 2020;144:152–7.
https://doi.org/10.1016/j.urology.2020.05.094
19.
Roy M, Wang F, Vo H, Teng D, Teodoro G, Farris AB, et al. Deep-learning-based accurate hepatic steatosis quantification for histological assessment of liver biopsies. Lab Invest. 2020;100(10):1367–83.
https://doi.org/10.1038/s41374-020-0463-y
20.
Salvi M, Molinaro L, Metovic J, Patrono D, Romagnoli R, Papotti M, et al. Fully automated quantitative assessment of hepatic steatosis in liver transplants. Comput Biol Med. 2020;123:103836.
https://doi.org/10.1016/j.compbiomed.2020.103836
21.
Kriegsmann M, Haag C, Weis CA, Steinbuss G, Warth A, Zgorzelski C, et al. Deep learning for the classification of small-cell and non-small-cell lung cancer. Cancers. 2020;12(6):1604–15.
https://doi.org/10.3390/cancers12061604
22.
Holmström O, Linder N, Ngasala B, Mårtensson A, Linder E, Lundin M, et al. Point-of-care mobile digital microscopy and deep learning for the detection of soil-transmitted helminths and Schistosoma haematobium. Glob Health Action. 2017;10(Suppl 3):1337325.
https://doi.org/10.1080/16549716.2017.1337325
23.
Osaku D, Cuba CF, Suzuki CTN, Gomes JF, Falcão AX. Automated diagnosis of intestinal parasites: a new hybrid approach and its benefits. Comput Biol Med. 2020;123:103917.
https://doi.org/10.1016/j.compbiomed.2020.103917
24.
Linder N, Turkki R, Walliander M, Mårtensson A, Diwan V, Rahtu E, et al. A malaria diagnostic tool based on computer vision screening and visualization of Plasmodium falciparum candidate areas in digitized blood smears. PLoS One. 2014;9(8):e104855.
https://doi.org/10.1371/journal.pone.0104855
25.
Manescu P, Shaw MJ, Elmi M, Neary-Zajiczek L, Claveau R, Pawar V, et al. Expert-level automated malaria diagnosis on routine blood films with deep neural networks. Am J Hematol. 2020;95(8):883–91.
https://doi.org/10.1002/ajh.25827
© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.